Mark Blaskovich
Mark Blaskovich
IMB Fellow, Institute for Molecular Bioscience, University of Queensland
Verified email at uq.edu.au
Title
Cited by
Cited by
Year
Antibiotics in the clinical pipeline in 2013
MS Butler, MA Blaskovich, MA Cooper
The Journal of antibiotics 66 (10), 571-591, 2013
4162013
Antibiotics in the clinical pipeline at the end of 2015
MS Butler, MAT Blaskovich, MA Cooper
The Journal of antibiotics 70 (1), 3-24, 2017
2352017
Glycopeptide antibiotics: back to the future
MS Butler, KA Hansford, MAT Blaskovich, R Halai, MA Cooper
The Journal of antibiotics 67 (9), 631-644, 2014
1352014
Unusual amino acids in medicinal chemistry
MAT Blaskovich
Journal of medicinal chemistry 59 (24), 10807-10836, 2016
1342016
Synthesis of a chiral serine aldehyde equivalent and its conversion to chiral. alpha.-amino acid derivatives
MA Blaskovich, GA Lajoie
Journal of the American Chemical Society 115 (12), 5021-5030, 1993
1141993
Drug discovery and protein tyrosine phosphatases
MAT Blaskovich
Current medicinal chemistry 16 (17), 2095-2176, 2009
1092009
Stereoselective synthesis of threo and erythro β-hydroxy and β-disubstituted-β-hydroxy α-amino acids
MA Blaskovich, G Evindar, NGW Rose, S Wilkinson, Y Luo, GA Lajoie
The Journal of Organic Chemistry 63 (11), 3631-3646, 1998
961998
Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β-hairpin peptides
IA Edwards, AG Elliott, AM Kavanagh, J Zuegg, MAT Blaskovich, ...
ACS infectious diseases 2 (6), 442-450, 2016
872016
Helping chemists discover new antibiotics
MAT Blaskovich, J Zuegg, AG Elliott, MA Cooper
ACS Infectious Diseases 1 (7), 285-287, 2015
862015
Recent discovery and development of protein tyrosine phosphatase inhibitors
HO Kim, MA Blaskovich
Expert Opinion on Therapeutic Patents 12 (6), 871-905, 2002
732002
Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B
A Gallardo-Godoy, C Muldoon, B Becker, AG Elliott, LH Lash, JX Huang, ...
Journal of medicinal chemistry 59 (3), 1068-1077, 2016
712016
Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents
AM Jarrad, T Karoli, MAT Blaskovich, D Lyras, MA Cooper
Journal of medicinal chemistry 58 (13), 5164-5185, 2015
632015
Antimicrobial silver in medicinal and consumer applications: A patent review of the past decade (2007–2017)
W Sim, RT Barnard, MAT Blaskovich, ZM Ziora
Antibiotics 7 (4), 93, 2018
622018
Highly efficient and versatile synthesis of libraries of constrained β-strand mimetics
CO Ogbu, MN Qabar, PD Boatman, J Urban, JP Meara, MD Ferguson, ...
Bioorganic & medicinal chemistry letters 8 (17), 2321-2326, 1998
601998
Developments in glycopeptide antibiotics
MAT Blaskovich, KA Hansford, MS Butler, ZG Jia, AE Mark, MA Cooper
ACS infectious diseases 4 (5), 715-735, 2018
542018
Evaluation of biomarkers for in vitro prediction of drug‐induced nephrotoxicity: comparison of HK‐2, immortalized human proximal tubule epithelial, and primary cultures of …
JX Huang, G Kaeslin, MV Ranall, MA Blaskovich, B Becker, MS Butler, ...
Pharmacology research & perspectives 3 (3), e00148, 2015
532015
Nitroimidazoles: molecular fireworks that combat a broad spectrum of infectious diseases
CW Ang, AM Jarrad, MA Cooper, MAT Blaskovich
Journal of Medicinal Chemistry 60 (18), 7636-7657, 2017
512017
Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis
AM Jarrad, A Debnath, Y Miyamoto, KA Hansford, R Pelingon, MS Butler, ...
European journal of medicinal chemistry 120, 353-362, 2016
512016
Solid-phase preparation of dienes
MA Blaskovich, M Kahn
The Journal of Organic Chemistry 63 (4), 1119-1125, 1998
511998
Mucin binding reduces colistin antimicrobial activity
JX Huang, MAT Blaskovich, R Pelingon, S Ramu, A Kavanagh, AG Elliott, ...
Antimicrobial agents and chemotherapy 59 (10), 5925-5931, 2015
482015
The system can't perform the operation now. Try again later.
Articles 1–20